Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 57

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

A Fully Integrated Online Platform For Real Time Monitoring Of Multiple Product Quality Attributes In Biopharmaceutical Processes For Monoclonal Antibody Therapeutics

Liu, Yang, Zhang, Chi, Chen, Jiangchao, Fernandez, Janice, Vellala, Pragna, Kulkarni, Tanmay A., Aguilar, Isaiah, Ritz, Diana, Lan, Kevin, Patel, Pramthesh, Liu, Aston·2022·Journal of Pharmaceutical Sciences

Abstract

In response to FDA's call for Quality by Design (QbD) in biopharmaceutical product development, the biopharmaceutical industry has been developing highly sensitive and specific technologies in the monitoring and controlling of product quality attributes for bioprocesses. We previously published the successful application of an off-line multi-attribute method (MAM) to monitor more than 20 critical quality attributes (CQA) with superior sensitivity for the upstream process. To further remove the hurdles of laborious process sampling and sample preparation associated with the offline method, we present here a fully integrated MAM based online platform for automated real time online process monitoring. This integrated system includes Modular Automated Sampling Technology (MAST) based aseptic sampling, multi-function Sequential Injection Analysis (SIA) sample preparation, UHPLC separation and high-resolution mass spectrometry (HRMS) analysis. Continuous automated daily monitoring of a 17-day cell culture process was successfully demonstrated for a model monoclonal antibody (mAb) molecule with similar specificity and sensitivity as we reported earlier. To the best of our knowledge, this is the first report of an end-to-end automated online MAM system, which would allow the MAM to be applied to routine bioprocess monitoring, potentially replacing multiple conventional low resolution and low sensitivity off-line methods. The online HPLC or HPLC/MS platform could be easily adapted to…

Overview

Integrity signals

Registry

Crossref · 10.1016/j.xphs.2021.09.011

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 2 references

Research works printed but not linked: 30

  1. Zitvogel, 2015, Cancer: antibodies regulate antitumor immunity, Nature, 7550, 35, 10.1038/nature14388 · DOI
  2. Chen, 2015, Anti-PD-1/PD-L1 therapy of human cancer: past, present, and future, J Clin Investig, 125, 3384, 10.1172/JCI80011 · DOI · Paper page
  3. Redman, 2015, Mechanisms of action of therapeutic antibodies for cancer, Mol Immunol, 67, 28, 10.1016/j.molimm.2015.04.002 · DOI · Paper page
  4. Chen, 2013, Oncology meets immunology: the cancer immunity cycle, Immunity, 39, 1, 10.1016/j.immuni.2013.07.012 · DOI · Paper page
  5. Wang, 2016, Simultaneous monitoring of oxidation, deamidation, isomerization, and glycosylation of monoclonal antibodies by liquid chromatography-mass spectrometry method with ultrafast tryptic digestion, MABs, 8, 1477, 10.1080/19420862.2016.1226715 · DOI
  6. Suurs, 2019, A review of bispecific antibodies and antibody constructs in oncology and clinical challenges, Pharmacol Thera, 201, 103, 10.1016/j.pharmthera.2019.04.006 · DOI · Paper page
  7. Rüttinger, 2018, BiTE antibodies: Directing T lymphocytes against tumor cells by bispecifity, J Onkol, 4
  8. Baldo, 2015, Chimeric fusion proteins used for therapy: indications, mechanisms, and safety, Drug Saf, 38, 455, 10.1007/s40264-015-0285-9 · DOI
  9. Fesnak, 2016, Engineered T cells: the promise and challenges of cancer immunotherapy, Nat Rev Cancer, 16, 566, 10.1038/nrc.2016.97 · DOI · Paper page
  10. Sheridan, 2015, First oncolytic virus edges towards approval in surprise vote, Nature Biotechnology, 33, 569, 10.1038/nbt0615-569 · DOI
  11. Carinhas, 2012, Systems biotechnology of animal cells: the road to prediction, Trends Biotechnol, 30, 377, 10.1016/j.tibtech.2012.03.004 · DOI
  12. Baik, 2014, Toward product attribute control: developments from genome sequencing, Curr Opin Biotechnol, 30, 40, 10.1016/j.copbio.2014.05.001 · DOI
  13. Streefland, 2013, Process analytical technology (PAT) tools for the cultivation step in biopharmaceutical production, Eng Life Sci, 13, 212, 10.1002/elsc.201200025 · DOI
  14. Patel, 2017, On-line ion exchange liquid chromatography as a process analytical technology for monoclonal antibody characterization in continuous bioprocessing, Anal. Chem, 89, 11357, 10.1021/acs.analchem.7b02228 · DOI
  15. Muteki, 2013, Quantitative structure retention relationship models in an analytical Quality by Design framework: simultaneously accounting for compound properties, mobile-phase conditions, and stationary-phase properties, Ind Eng Chem Res, 52, 12269, 10.1021/ie303459a · doi:10.1021/ie303459a
  16. Zalai, 2015, Advanced development strategies for biopharmaceutical cell culture processes, Curr Pharm Biotechnol, 16, 983, 10.2174/1389201016666150724100450 · doi:10.2174/1389201016666150724100450
  17. Teixeira, 2009, Advances in on-line monitoring and control of mammalian cell cultures: supporting the PAT initiative, Biotechnol Adv, 27, 726, 10.1016/j.biotechadv.2009.05.003 · DOI · Paper page
  18. Zhao, 2015, Advances in process monitoring tools for cell culture bioprocesses, Eng. Life Sci, 15, 459, 10.1002/elsc.201500006 · DOI · Paper page
  19. Buckley, 2017, Applications of Raman spectroscopy in biopharmaceutical manufacturing: a short review, Appl Spectrosc, 71, 1085, 10.1177/0003702817703270 · DOI · Paper page
  20. Chelius, 2008, Automated tryptic digestion procedure for HPLC/MS/MS peptide mapping of immunoglobulin gamma antibodies in pharmaceutics, J Pharm Biomed Anal, 47, 285, 10.1016/j.jpba.2008.01.018 · doi:10.1016/j.jpba.2008.01.018
  21. Ren, 2020, Advancing mass spectrometry technology in cGMP environments, Trends Biotechnol, 38, 1051, 10.1016/j.tibtech.2020.06.007 · DOI
  22. Lambertus, 2019, Development of universal, automated sample acquisition, preparation, and delivery devices and methods for pharmaceutical applications, Organic Process Res Dev, 23, 189, 10.1021/acs.oprd.8b00280 · DOI
  23. Richardson, 2011, Automated in-solution protein digestion using a commonly available high-performance liquid chromatography autosampler, Anal Biochem, 411, 284, 10.1016/j.ab.2011.01.019 · DOI
  24. Wu, 2015, Micro sequential injection system as the interfacing device for process analytical applications, Biotechnol Prog, 31, 607, 10.1002/btpr.2055 · DOI
  25. Ren, 2009, An improved trypsin digestion method minimizes digestion-induced modifications on proteins, Anal Biochem, 392, 12, 10.1016/j.ab.2009.05.018 · DOI · Paper page
  26. Liu, 2020, Automated mass spectrometry multi-attribute method analyses for process development and characterization of mAbs, J Pharm Sci, 109, 3319, 10.1016/j.xphs.2020.07.029 · DOI
  27. Jakes, 2021, Tracking the behavior of monoclonal antibody product quality attributes using a multi-attribute method workflow, J Am Soc Mass Spectrom, 10.1021/jasms.0c00432 · DOI
  28. Dong, 2016, High-throughput, automated protein A purification platform with multi attribute LC−MS analysis for advanced cell culture process monitoring, Anal Chem, 88, 8673, 10.1021/acs.analchem.6b01956 · DOI
  29. Song, 2021, Automated mass spectrometry multi-attribute method analyses for process development and characterization of mAbs, J Chromatogr B, 1166, 10.1016/j.jchromb.2021.122540 · DOI
  30. Xu, 2017, A quadrupole dalton-based multi-attribute method for product characterization, process development, and quality control of therapeutic proteins, MAbs, 9, 1186, 10.1080/19420862.2017.1364326 · DOI

Cited by

See all 57

Metadata

Authors
Liu, Y., Zhang, C., Chen, J., Fernandez, J., Vellala, P., Kulkarni, T. A., Aguilar, I., Ritz, D., Lan, K., Patel, P., & Liu, A.
Venue
Journal of Pharmaceutical Sciences
Publisher
Elsevier BV
Published
2022-02
Volume
111
Issue
2
Pages
358-367
ISSN
0022-3549
Cited by
57
References
2
Language
en
Licence
  • www.elsevier.com/tdm/userlicense/1.0/ (tdm)
  • www.elsevier.com/legal/tdmrep-license (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A Fully Integrated Online Platform For Real Time Monitoring Of Multiple Product Quality Attributes In Biopharmaceutical Processes For Monoclonal Antibody Therapeutics. https://app.cochat.ai/papers/10.1016/j.xphs.2021.09.011
The paper
Liu, Y., Zhang, C., Chen, J., Fernandez, J., Vellala, P., Kulkarni, T. A., Aguilar, I., Ritz, D., Lan, K., Patel, P., & Liu, A. (2022). A Fully Integrated Online Platform For Real Time Monitoring Of Multiple Product Quality Attributes In Biopharmaceutical Processes For Monoclonal Antibody Therapeutics. Journal of Pharmaceutical Sciences. https://doi.org/10.1016/j.xphs.2021.09.011

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.